Pharmacology

Resource Center

News
Research Summaries
Resources
From the Journal
Insights
Podcasts Q&As Videos
Interactive
Quizzes
Events & Education
ASHP Midyear

Research Summaries

Conference Coverage
cc
Conference Coverage
HIV Persistence Reduced After Doubling Antiretroviral Therapy in Patients
04/18/2023
Researchers evaluated the impact an intensified dose of dolutegravir had on patients living with HIV. Their research was presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2023...
04/18/2023
Research Summary
Research Summary
Most Adults With Diabetes Can Use GLP-1 RAs, SGLT-2 Inhibitors But Don't
04/17/2023
Researchers set out to determine the percentage of people in the United States with type 2 diabetes who meet the recommended criteria to use GLP-1 receptor agonists and SGLT-2 inhibitors as well as patients...
04/17/2023
FDA Alerts
FDA Alerts
FDA Approves Over-The-Counter Naloxone Spray for Opioid Overdoses
04/03/2023
Jessica Ganga
The FDA approves the overdose medication for over-the-counter use after data supports its safe use.
04/03/2023
COVID-19 Roundup
COVID-19 Roundup
An Alternative to Nirmatrelvir-Ritonavir Shows Efficacy, Two-Dose Vaccine Regimen Protects Pregnant Women, Infants Against COVID-19 Variants, and More
03/29/2023
Jessica Ganga
This COVID-19 roundup includes research on an alternative therapy to nirmatrelvir-ritonavir, a vaccine regimen that protects pregnant women and infants against certain variants, pegylated interferon lambda...
03/29/2023
CONFERENCE COVERAGE
CC
CONFERENCE COVERAGE
Hair Regrowth Sustained Over 48 Weeks in Ritlecitinib-Treated Patients With Alopecia Areata
03/29/2023
Anthony Calabro, MA
In a post-hoc analysis of the ALLEGRO phase 2b/3 trial, researchers evaluated whether scalp, eyebrow, and eyelash hair regrowth would continue over 48 weeks in patients with alopecia areata treated with...
03/29/2023
Conference Coverage
Conference Coverage
Janus Kinase Inhibitors a Treatment Option for Alopecia Areata
03/28/2023
Jessica Ganga
Researchers evaluated the efficacy of Janus kinase inhibitors in adult patients with alopecia areata. Their research was presented at the American Academy of Dermatology’s 2023 annual meeting in New...
03/28/2023
Enzyme Replacement Therapy
Enzyme Replacement Therapy
First Enzyme Replacement Therapy to Treat Rare Genetic Disorder Approved
03/17/2023
Jessica Ganga
Following a multicenter study, the FDA has approved the first enzyme replacement therapy in the United States to treat alpha-mannosidosis.
03/17/2023
Research Summary
Research Summary
Treatment for Type 2 Diabetes Reduces Major CV Events in Men
02/28/2023
The researchers evaluated the effects of two medications used for type 2 diabetes patients on reducing major cardiovascular events in both men and women.
02/28/2023
Research Summary
Research Summary
Inflammation Reduction Medications May Lower Dementia Risk in Patients With Rheumatoid Arthritis
02/27/2023
Researchers examined the association between inflammation-reducing medications and dementia risk in patients with rheumatoid arthritis.
02/27/2023
Research Summary
Research Summary
AHA Releases Statement on Hypertension Induced by Anticancer Therapy
02/23/2023
The American Heart Association (AHA) addresses the adverse effect of hypertension in patients receiving anticancer therapies and how the disease should be managed.
02/23/2023